ContextVision Webcast Q4 2021
ContextVision – Aiming to build the company’s first modern pathology lab
ContextVision shows strong momentum in Q4, leading to record sales for the year
STOCKHOLM – Feb 16, 2022- ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today reports its fourth quarter and full year 2021 results. Total sales 2021 reached 98.1 MSEK (94.7), which is the highest revenue in the history of the company. After a slow […]
Vi letar fler medarbetare till vårt fantastiska team av Applikationsingenjörer!
STOCKHOLM – February 14, 2022 – ContextVision, a medical technology software company specializing in image quality and artificial intelligence, announces a new executive leadership team following the spin out of the company’s digital pathology arm into a new standalone business. Previous leaders at ContextVision will assume new roles, including the appointment of Ola Lindblad as […]
We are looking for colleagues to join our fantastic team of Application Engineers!
STOCKHOLM – February 14, 2022 – ContextVision, a medical technology software company specializing in image quality and artificial intelligence, announces a new executive leadership team following the spin out of the company’s digital pathology arm into a new standalone business. Previous leaders at ContextVision will assume new roles, including the appointment of Ola Lindblad as […]
ContextVision Announces New Leadership Team, Appoints Ola Lindblad as CEO
STOCKHOLM – February 14, 2022 – ContextVision, a medical technology software company specializing in image quality and artificial intelligence, announces a new executive leadership team following the spin out of the company’s digital pathology arm into a new standalone business. Previous leaders at ContextVision will assume new roles, including the appointment of Ola Lindblad as […]
ContextVision – Information regarding dividend and reverse share split in Inify Laboratories
ContextVision AB (“ContextVision” or the “Company”) will, in accordance with the press release published on 2 February 2022, distribute all shares in its wholly-owned subsidiary INIFY Laboratories AB (“INIFY”) to the shareholders of ContextVision. The shares in INIFY are expected to be delivered to shareholders who have their shares registered at Euroclear Sweden AB around […]
ContextVision confirms the value of the upcoming dividend
Stockholm, February 7th, 2022, in accordance with the regulations of the Oslo Stock Exchange. ContextVision hereby confirms the value of the upcoming dividend. In accordance with the information in the notice to the Extraordinary General Meeting published on November 15, 2021, the company confirms that the value of the dividend distribution in form of the […]
ContextVision announces resolution regarding record date for dividend
Stockholm, February 2nd, at the extraordinary general meeting in ContextVision AB (“ContextVision” or the “Company”) held on 10 December 2021 the meeting resolved to distribute all shares in the wholly-owned company INIFY Laboratories AB, company registration number 559345-4431 (“INIFY”) to the shareholders of the Company. The board of directors has determined the record date for […]